Goldman Sachs’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $79.4K | Sell |
|
|||||
|
2022
Q4 | $141K | Sell |
|
|||||
|
2022
Q3 | $378K | Sell |
|
|||||
|
2022
Q2 | $620K | Sell |
|
|||||
|
2022
Q1 | $2.66M | Sell |
|
|||||
|
2021
Q4 | $6.02M | Buy |
|
|||||
|
2021
Q3 | $5.01M | Buy |
|
|||||
|
2021
Q2 | $1.12M | Buy |
|
|||||
|
2021
Q1 | $1.55M | Buy |
|
|||||
|
2020
Q4 | $249K | Sell |
|
|||||
|
2020
Q3 | $310K | Sell |
|
|||||
|
2020
Q2 | $392K | Sell |
|
|||||
|
2020
Q1 | $380K | Sell |
|
|||||
|
2019
Q4 | $969K | Sell |
|
|||||
|
2019
Q3 | $456K | Buy |
|
|||||
|
2019
Q2 | $464K | Buy |
|
|||||
|
2019
Q1 | $560K | Sell |
|
|||||
|
2018
Q4 | $321K | Sell |
|
|||||
|
2018
Q3 | $661K | Buy |
|
|||||
|
2018
Q2 | $643K | Buy |
|
|||||
|
2018
Q1 | $1.72M | Buy |
|
|||||
|
2017
Q4 | $788K | Sell |
|
|||||
|
2017
Q3 | $1.79M | Buy |
|
|||||
|
2017
Q2 | $977K | Buy |
|
|||||
|
2017
Q1 | $271K | Buy |
|